These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 39157539

  • 1. Establishing the Safety and Efficacy of Bedaquiline-Containing Regimen for the Treatment of Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Jihwaprani MC, Sun Y, Rizky WC, Sula I, Saquib N.
    Pulm Med; 2024; 2024():5542658. PubMed ID: 39157539
    [Abstract] [Full Text] [Related]

  • 2. A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT.
    Gao J, Gao M, Du J, Pang Y, Mao G, Lounis N, Bakare N, Jiang Y, Zhan Y, Liu Y, Li L, Trial Team.
    Trials; 2024 Apr 01; 25(1):227. PubMed ID: 38561815
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Initial experience of bedaquiline implementation under the National TB Programme at NITRD, Delhi, India.
    Sarin R, Singla N, Vohra V, Singla R, Puri MM, Munjal S, Khalid UK, Myneedu VP, Kumar Verma A, Mathuria KK.
    Indian J Tuberc; 2019 Jan 01; 66(1):209-213. PubMed ID: 30878071
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of the all-oral bedaquiline-containing regimen as treatment for pediatric multidrug/rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study.
    Sun WW, Yang M, Chen XH, Fan LC, Wu HY, Zhang SJ, Chen Y, Fan L.
    Expert Rev Anti Infect Ther; 2024 Apr 01; 22(4):219-227. PubMed ID: 37982155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early treatment outcome of bedaquiline plus optimised background regimen in drug resistant tuberculosis patients.
    Barvaliya SV, Desai MK, Panchal JR, Solanki RN.
    Indian J Tuberc; 2020 Apr 01; 67(2):222-230. PubMed ID: 32553316
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bedaquiline versus injectable containing regimens for rifampicin-resistant and multidrug-resistant tuberculosis in a reference center in Brazil - a real-world evidence study using a retrospective design.
    Santos AP, Benace CJ, de Medeiros Leung JA, Kritski AL, de Queiroz Mello FC.
    BMC Infect Dis; 2024 Oct 07; 24(1):1112. PubMed ID: 39375590
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the side effect of QTc interval prolongation in the bedaquiline regimen in drug resistant tuberculosis patients.
    Ardhianto D, Suharjono, Soedarsono, Fatmawati U.
    J Basic Clin Physiol Pharmacol; 2021 Jun 25; 32(4):421-427. PubMed ID: 34214323
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis.
    Ionescu AM, Mpobela Agnarson A, Kambili C, Metz L, Kfoury J, Wang S, Williams A, Singh V, Thomas A.
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec 25; 18(6):677-689. PubMed ID: 30073886
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early efficacy and safety of Bedaquiline and Delamanid given together in a "Salvage Regimen" for treatment of drug-resistant tuberculosis.
    Sarin R, Vohra V, Singla N, Singla R, Puri MM, Munjal SK, Khalid UK, Myneedu VP, Verma A, Mathuria KK.
    Indian J Tuberc; 2019 Jan 25; 66(1):184-188. PubMed ID: 30878066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.